Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APLT |
---|---|---|
09:32 ET | 52087 | 6.0484 |
09:34 ET | 17792 | 5.8607 |
09:36 ET | 1702 | 5.96 |
09:38 ET | 12503 | 5.93 |
09:39 ET | 4160 | 5.985 |
09:41 ET | 5660 | 5.955 |
09:43 ET | 5816 | 5.99 |
09:45 ET | 15709 | 6.03 |
09:48 ET | 2100 | 6.0368 |
09:50 ET | 1176 | 6.055 |
09:52 ET | 2495 | 6.03 |
09:54 ET | 3080 | 6.0337 |
09:56 ET | 1700 | 6 |
09:57 ET | 9474 | 6.01 |
09:59 ET | 7765 | 5.94 |
10:01 ET | 1216 | 5.92 |
10:03 ET | 1118 | 5.88 |
10:06 ET | 1023 | 5.8358 |
10:08 ET | 2959 | 5.82 |
10:10 ET | 12550 | 5.82 |
10:12 ET | 3100 | 5.81 |
10:14 ET | 2345 | 5.81 |
10:15 ET | 1478 | 5.85 |
10:17 ET | 600 | 5.855 |
10:19 ET | 500 | 5.86 |
10:21 ET | 4685 | 5.86 |
10:24 ET | 2059 | 5.82 |
10:26 ET | 2252 | 5.81 |
10:28 ET | 1323 | 5.84 |
10:30 ET | 1749 | 5.8 |
10:32 ET | 100 | 5.78 |
10:33 ET | 300 | 5.78 |
10:35 ET | 200 | 5.78 |
10:37 ET | 1152 | 5.81 |
10:39 ET | 5167 | 5.78 |
10:42 ET | 2900 | 5.75 |
10:44 ET | 1000 | 5.755 |
10:46 ET | 600 | 5.73 |
10:48 ET | 1115 | 5.74 |
10:50 ET | 635 | 5.775 |
10:51 ET | 400 | 5.78 |
10:53 ET | 200 | 5.76 |
10:55 ET | 670 | 5.76 |
10:57 ET | 1689 | 5.7699 |
11:00 ET | 18275 | 5.71 |
11:02 ET | 8433 | 5.7 |
11:04 ET | 1100 | 5.7 |
11:06 ET | 1200 | 5.71 |
11:08 ET | 33441 | 5.8 |
11:09 ET | 14419 | 5.75 |
11:11 ET | 794 | 5.765 |
11:13 ET | 5200 | 5.75 |
11:15 ET | 1700 | 5.73 |
11:20 ET | 5601 | 5.74 |
11:22 ET | 1000 | 5.735 |
11:24 ET | 1300 | 5.72 |
11:26 ET | 3793 | 5.72 |
11:27 ET | 1306 | 5.71 |
11:29 ET | 200 | 5.7 |
11:31 ET | 803 | 5.685 |
11:33 ET | 400 | 5.7 |
11:36 ET | 487 | 5.685 |
11:38 ET | 600 | 5.7 |
11:40 ET | 200 | 5.69 |
11:42 ET | 1028 | 5.68 |
11:44 ET | 7527 | 5.62 |
11:45 ET | 862 | 5.6 |
11:47 ET | 1750 | 5.6138 |
11:49 ET | 4520 | 5.61 |
11:51 ET | 4146 | 5.605 |
11:54 ET | 7893 | 5.59 |
11:56 ET | 100 | 5.59 |
11:58 ET | 3094 | 5.58 |
12:00 ET | 3028 | 5.58 |
12:02 ET | 3960 | 5.605 |
12:03 ET | 2440 | 5.61 |
12:05 ET | 1100 | 5.61 |
12:07 ET | 500 | 5.62 |
12:09 ET | 7416 | 5.61 |
12:12 ET | 11824 | 5.63 |
12:14 ET | 2852 | 5.66 |
12:16 ET | 1100 | 5.66 |
12:18 ET | 2267 | 5.66 |
12:20 ET | 1009 | 5.67 |
12:21 ET | 2304 | 5.655 |
12:23 ET | 1582 | 5.66 |
12:25 ET | 475 | 5.67 |
12:27 ET | 600 | 5.67 |
12:30 ET | 600 | 5.68 |
12:32 ET | 1404 | 5.69 |
12:34 ET | 2110 | 5.69 |
12:36 ET | 12284 | 5.73 |
12:38 ET | 200 | 5.73 |
12:39 ET | 491 | 5.73 |
12:41 ET | 650 | 5.72 |
12:43 ET | 2200 | 5.71 |
12:45 ET | 308 | 5.7 |
12:48 ET | 1506 | 5.69 |
12:50 ET | 925 | 5.68 |
12:52 ET | 200 | 5.69 |
12:54 ET | 900 | 5.68 |
12:56 ET | 500 | 5.69 |
12:57 ET | 600 | 5.705 |
12:59 ET | 1061 | 5.72 |
01:01 ET | 500 | 5.715 |
01:06 ET | 1975 | 5.7 |
01:08 ET | 1152 | 5.71 |
01:10 ET | 751 | 5.72 |
01:12 ET | 1700 | 5.71 |
01:14 ET | 1000 | 5.73 |
01:15 ET | 3220 | 5.74 |
01:19 ET | 3128 | 5.73 |
01:21 ET | 800 | 5.74 |
01:24 ET | 502 | 5.745 |
01:26 ET | 1000 | 5.735 |
01:28 ET | 2806 | 5.71 |
01:30 ET | 502 | 5.715 |
01:32 ET | 300 | 5.71 |
01:35 ET | 112 | 5.715 |
01:37 ET | 2076 | 5.715 |
01:39 ET | 4770 | 5.7 |
01:44 ET | 306 | 5.7 |
01:46 ET | 2101 | 5.7 |
01:48 ET | 573 | 5.69 |
01:50 ET | 204 | 5.69 |
01:51 ET | 100 | 5.69 |
01:53 ET | 306 | 5.7 |
01:55 ET | 1678 | 5.72 |
01:57 ET | 2432 | 5.695 |
02:00 ET | 206 | 5.69 |
02:02 ET | 2574 | 5.72 |
02:04 ET | 1600 | 5.705 |
02:06 ET | 420 | 5.7 |
02:08 ET | 136 | 5.7 |
02:09 ET | 914 | 5.715 |
02:11 ET | 300 | 5.715 |
02:13 ET | 616 | 5.71 |
02:15 ET | 600 | 5.72 |
02:18 ET | 741 | 5.715 |
02:22 ET | 3596 | 5.695 |
02:24 ET | 1086 | 5.705 |
02:26 ET | 500 | 5.71 |
02:27 ET | 2618 | 5.715 |
02:29 ET | 4784 | 5.71 |
02:31 ET | 226 | 5.7 |
02:33 ET | 123 | 5.7 |
02:36 ET | 763 | 5.71 |
02:38 ET | 500 | 5.71 |
02:40 ET | 4043 | 5.74 |
02:42 ET | 1085 | 5.74 |
02:44 ET | 5771 | 5.74 |
02:45 ET | 4446 | 5.73 |
02:47 ET | 1209 | 5.74 |
02:51 ET | 1000 | 5.725 |
02:54 ET | 4414 | 5.73 |
02:56 ET | 6869 | 5.73 |
02:58 ET | 1053 | 5.725 |
03:00 ET | 127 | 5.735 |
03:02 ET | 1987 | 5.73 |
03:03 ET | 3654 | 5.715 |
03:05 ET | 500 | 5.72 |
03:07 ET | 1632 | 5.7199 |
03:09 ET | 3638 | 5.71 |
03:12 ET | 446 | 5.715 |
03:14 ET | 2218 | 5.715 |
03:16 ET | 900 | 5.715 |
03:18 ET | 5701 | 5.71 |
03:20 ET | 1493 | 5.7 |
03:21 ET | 3734 | 5.685 |
03:23 ET | 1376 | 5.685 |
03:25 ET | 2633 | 5.68 |
03:27 ET | 300 | 5.67 |
03:30 ET | 51847 | 5.74 |
03:32 ET | 11085 | 5.74 |
03:34 ET | 758 | 5.7384 |
03:36 ET | 8890 | 5.745 |
03:38 ET | 6077 | 5.735 |
03:39 ET | 2181 | 5.735 |
03:41 ET | 4490 | 5.715 |
03:43 ET | 2425 | 5.71 |
03:45 ET | 2300 | 5.71 |
03:48 ET | 1014 | 5.7 |
03:50 ET | 5339 | 5.715 |
03:52 ET | 14398 | 5.68 |
03:54 ET | 8542 | 5.67 |
03:56 ET | 20382 | 5.64 |
03:57 ET | 18366 | 5.635 |
03:59 ET | 46316 | 5.63 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Applied Therapeutics Inc | 678.7M | -2.9x | --- |
SS Innovations International Inc | 665.9M | -27.3x | --- |
ProKidney Corp | 676.7M | -4.3x | --- |
Larimar Therapeutics Inc | 681.4M | -10.9x | --- |
Prime Medicine Inc | 693.8M | -3.1x | --- |
Arbutus Biopharma Corp | 707.7M | -8.8x | --- |
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $678.7M |
---|---|
Revenue (TTM) | $-477.0K |
Shares Outstanding | 114.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.02 |
EPS | $-1.91 |
Book Value | $-0.20 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.